Med­i­cal de­vice start-up at­tracts global in­ter­est

Exporter - - MAKING NEWS -

In­ter­na­tional med­i­cal com­pa­nies are cir­cling New Zealand med­i­cal de­vice start-up KM Med­i­cal and MD Richard McCul­loch couldn’t be hap­pier.

“Med­i­cal de­vices aren’t like other in­ven­tions,” he says. “You can’t just go straight to man­u­fac­ture with­out cer­ti­fi­ca­tion to FDA (US) and CE (Europe) reg­u­la­tory com­pli­ance.

And that comes at a huge cost.”

After five years of work, Auck­land-based KM Med­i­cal has de­vel­oped tech­nol­ogy for a plat­form pro­vid­ing au­to­mated de­liv­ery of re­sus­ci­ta­tion and ven­ti­la­tion.

AJ Park has en­sured the in­tel­lec­tual prop­erty is pro­tected by in­ter­na­tional patents and their strength can be gauged by the re­cent grant­ing of both Chi­nese and Rus­sian patents.

The plat­form fea­tures world-lead­ing tech­nol­ogy, mak­ing it far smaller, lighter, more power-ef­fi­cient, and lower-cost than other res­pi­ra­tory so­lu­tions.

The first prod­uct to be de­vel­oped from the plat­form will be a Neonatal Re­sus­ci­ta­tor and

Trans­port Ven­ti­la­tor and McCul­loch is par­tic­u­larly ex­cited about bring­ing it to mar­ket.

“The pub­lic health ben­e­fits are im­mense,” he says, “and when we com­plete our in­vest­ment round we’ll have fund­ing to at­tain reg­u­la­tory com­pli­ance cer­ti­fi­ca­tion, com­mer­cialise the Neonatal Re­sus­ci­ta­tor and start sav­ing new­borns’ lives.”

A mar­ket val­i­da­tion study by a lead­ing Euro­pean med­i­cal mar­ket re­search company has con­firmed a mar­ket op­por­tu­nity of US$640 mil­lion over ten years for the Neonatal Re­sus­ci­ta­tor alone.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.